Warning letter
NatureLab Corp.: warning letter of Jul 12, 2022
FDA warning letter 625768 · Division of Pharmaceutical Quality Operations II
Key facts
| Reference number | 625768 |
|---|---|
| Company | NatureLab Corp. |
| Subject | CGMP/Dietary Supplement/Adulterated |
| Issue date | Jul 12, 2022 |
| Posted date | Nov 8, 2022 |
| Issuing office | Division of Pharmaceutical Quality Operations II |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4, 101.36, 111, 111.73, 111.75, 111.210, 111.260, 111.553, 111.560, 111.570, 101.3(g), 101.36(b)(1)(ii) and 44 more |
| Inspection city | Carrollton |
| Inspection ZIP | 75006 |
| Inspection start date | Oct 18, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: